Geoff Meacham
Stock Analyst at Citigroup
(4.26)
# 396
Out of 5,042 analysts
273
Total ratings
60.69%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Neutral | $30 → $28 | $26.74 | +4.71% | 11 | Oct 23, 2025 | |
| PTGX Protagonist Therapeutics | Maintains: Buy | $72 → $96 | $74.86 | +28.24% | 2 | Oct 17, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $42 → $50 | $35.72 | +39.98% | 2 | Oct 17, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $60 → $80 | $58.56 | +36.61% | 6 | Oct 17, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $45 → $50 | $38.93 | +28.44% | 4 | Oct 17, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $12 → $20 | $14.17 | +41.14% | 5 | Oct 17, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $78 → $93 | $67.61 | +37.55% | 4 | Oct 17, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $650 → $660 | $577.95 | +14.20% | 23 | Oct 13, 2025 | |
| MRK Merck & Co. | Reinstates: Neutral | $84 → $95 | $87.49 | +8.58% | 8 | Oct 13, 2025 | |
| GILD Gilead Sciences | Maintains: Buy | $125 → $135 | $120.94 | +11.63% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $220 → $251 | $227.99 | +10.09% | 20 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $550 → $575 | $421.39 | +36.45% | 6 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $65 | $49.15 | +32.25% | 7 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $14 | $5.98 | +134.11% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $2.21 | +307.24% | 5 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $305 → $310 | $291.76 | +6.25% | 13 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $125 → $135 | $149.89 | -9.93% | 15 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $50 | $66.40 | -24.70% | 9 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $37.26 | +12.72% | 3 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $54 | $54.26 | -0.48% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $84.68 | +29.90% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $8.52 | -29.58% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $105.66 | +32.50% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $2.63 | -61.98% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $53.32 | +78.17% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $14.79 | +69.03% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $54.48 | +89.06% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $2.33 | +71.67% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $825.45 | +33.26% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $17.64 | +13.38% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $14.23 | +117.85% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $190.40 | -10.71% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $24.90 | +92.77% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $43.83 | +36.89% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.36 | +49.25% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $1.82 | +834.07% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $24.76 | +81.74% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $2.33 | +930.04% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $7.55 | -47.02% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $2.38 | +1,076.47% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.58 | +5,789.49% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $2.71 | +1,191.51% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $8.43 | +6,127.76% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.56 | +2,592.31% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $8.72 | +129.36% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.63 | +3,058.06% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $5.23 | +72.08% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $13.03 | +360.48% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.29 | +63.36% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $17.74 | +29.65% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $91.28 | -10.17% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $418.58 | -77.30% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $15.41 | +419.14% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $144.00 | -6.25% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $9.82 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $1.66 | +1,104.82% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $16.60 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $463.43 | -65.91% | 5 | Nov 8, 2017 |
Moderna
Oct 23, 2025
Maintains: Neutral
Price Target: $30 → $28
Current: $26.74
Upside: +4.71%
Protagonist Therapeutics
Oct 17, 2025
Maintains: Buy
Price Target: $72 → $96
Current: $74.86
Upside: +28.24%
NewAmsterdam Pharma Company
Oct 17, 2025
Maintains: Buy
Price Target: $42 → $50
Current: $35.72
Upside: +39.98%
Kymera Therapeutics
Oct 17, 2025
Maintains: Buy
Price Target: $60 → $80
Current: $58.56
Upside: +36.61%
Kiniksa Pharmaceuticals International,
Oct 17, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $38.93
Upside: +28.44%
Amylyx Pharmaceuticals
Oct 17, 2025
Maintains: Buy
Price Target: $12 → $20
Current: $14.17
Upside: +41.14%
CRISPR Therapeutics AG
Oct 17, 2025
Maintains: Buy
Price Target: $78 → $93
Current: $67.61
Upside: +37.55%
Regeneron Pharmaceuticals
Oct 13, 2025
Maintains: Buy
Price Target: $650 → $660
Current: $577.95
Upside: +14.20%
Merck & Co.
Oct 13, 2025
Reinstates: Neutral
Price Target: $84 → $95
Current: $87.49
Upside: +8.58%
Gilead Sciences
Oct 8, 2025
Maintains: Buy
Price Target: $125 → $135
Current: $120.94
Upside: +11.63%
Oct 3, 2025
Maintains: Neutral
Price Target: $220 → $251
Current: $227.99
Upside: +10.09%
Oct 2, 2025
Maintains: Buy
Price Target: $550 → $575
Current: $421.39
Upside: +36.45%
Sep 15, 2025
Maintains: Buy
Price Target: $56 → $65
Current: $49.15
Upside: +32.25%
Aug 27, 2025
Upgrades: Buy
Price Target: $12 → $14
Current: $5.98
Upside: +134.11%
Aug 25, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $2.21
Upside: +307.24%
Aug 6, 2025
Maintains: Neutral
Price Target: $305 → $310
Current: $291.76
Upside: +6.25%
Aug 1, 2025
Maintains: Neutral
Price Target: $125 → $135
Current: $149.89
Upside: -9.93%
Jul 28, 2025
Maintains: Neutral
Price Target: $40 → $50
Current: $66.40
Upside: -24.70%
Jul 22, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $37.26
Upside: +12.72%
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $54.26
Upside: -0.48%
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $84.68
Upside: +29.90%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $8.52
Upside: -29.58%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $105.66
Upside: +32.50%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $2.63
Upside: -61.98%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $53.32
Upside: +78.17%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $14.79
Upside: +69.03%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $54.48
Upside: +89.06%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $2.33
Upside: +71.67%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $825.45
Upside: +33.26%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $17.64
Upside: +13.38%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $14.23
Upside: +117.85%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $190.40
Upside: -10.71%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $24.90
Upside: +92.77%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $43.83
Upside: +36.89%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.36
Upside: +49.25%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $1.82
Upside: +834.07%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $24.76
Upside: +81.74%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $2.33
Upside: +930.04%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $7.55
Upside: -47.02%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $2.38
Upside: +1,076.47%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.58
Upside: +5,789.49%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $2.71
Upside: +1,191.51%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $8.43
Upside: +6,127.76%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.56
Upside: +2,592.31%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $8.72
Upside: +129.36%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.63
Upside: +3,058.06%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $5.23
Upside: +72.08%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $13.03
Upside: +360.48%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.29
Upside: +63.36%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $17.74
Upside: +29.65%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $91.28
Upside: -10.17%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $418.58
Upside: -77.30%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $15.41
Upside: +419.14%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $144.00
Upside: -6.25%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $9.82
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $1.66
Upside: +1,104.82%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $16.60
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $463.43
Upside: -65.91%